A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice
Identifieur interne : 005A01 ( Main/Exploration ); précédent : 005A00; suivant : 005A02A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice
Auteurs : Naomi Takasuka ; Hideki Fujii ; Yoshimasa Takahashi ; Masataka Kasai ; Shigeru Morikawa ; Shigeyuki Itamura ; Koji Ishii ; Masahiro Sakaguchi ; Kazuo Ohnishi ; Masamichi Ohshima ; Shu-Ichi Hashimoto ; Takato Odagiri ; Masato Tashiro ; Hiroshi Yoshikura [Japon] ; Toshitada Takemori ; Yasuko Tsunetsugu-YokotaSource :
- International Immunology [ 0953-8178 ] ; 2004.
Descripteurs français
- KwdFr :
- Adjuvants immunologiques (administration et posologie), Alun (administration et posologie), Animaux, Immunoglobuline G (sang), Injections sous-cutanées, Production d'anticorps, Protéines virales (immunologie), Souris, Spécificité des anticorps, Syndrome respiratoire aigu sévère (), Technique de Western, Vaccins antiviraux (administration et posologie), Vaccins inactivés (administration et posologie), Virion (immunologie), Virus du SRAS (immunologie).
- MESH :
- administration et posologie : Adjuvants immunologiques, Alun, Vaccins antiviraux, Vaccins inactivés.
- immunologie : Protéines virales, Virion, Virus du SRAS.
- sang : Immunoglobuline G.
- Animaux, Injections sous-cutanées, Production d'anticorps, Souris, Spécificité des anticorps, Syndrome respiratoire aigu sévère, Technique de Western.
English descriptors
- KwdEn :
- Adjuvants, Immunologic (administration & dosage), Alum Compounds (administration & dosage), Animals, Antibody Formation, Antibody Specificity, Blotting, Western, Immunoglobulin G (blood), Injections, Subcutaneous, Mice, SARS Virus (immunology), Severe Acute Respiratory Syndrome (prevention & control), Vaccines, Inactivated (administration & dosage), Viral Proteins (immunology), Viral Vaccines (administration & dosage), Virion (immunology).
- MESH :
- chemical , administration & dosage : Adjuvants, Immunologic, Alum Compounds, Vaccines, Inactivated, Viral Vaccines.
- chemical , blood : Immunoglobulin G.
- immunology : SARS Virus, Viral Proteins, Virion.
- prevention & control : Severe Acute Respiratory Syndrome.
- Animals, Antibody Formation, Antibody Specificity, Blotting, Western, Injections, Subcutaneous, Mice.
Abstract
The recent emergence of severe acute respiratory syndrome (SARS) was caused by a novel coronavirus, SARS-CoV. It spread rapidly to many countries and developing a SARS vaccine is now urgently required. In order to study the immunogenicity of UV-inactivated purified SARS-CoV virion as a vaccine candidate, we subcutaneously immunized mice with UV-inactivated SARS-CoV with or without an adjuvant. We chose aluminum hydroxide gel (alum) as an adjuvant, because of its long safety history for human use. We observed that the UV-inactivated SARS-CoV virion elicited a high level of humoral immunity, resulting in the generation of long-term antibody secreting and memory B cells. With the addition of alum to the vaccine formula, serum IgG production was augmented and reached a level similar to that found in hyper-immunized mice, though it was still insufficient to elicit serum IgA antibodies. Notably, the SARS-CoV virion itself was able to induce long-term antibody production even without an adjuvant. Anti-SARS-CoV antibodies elicited in mice recognized both the spike and nucleocapsid proteins of the virus and were able to neutralize the virus. Furthermore, the UV-inactivated virion induced regional lymph node T-cell proliferation and significant levels of cytokine production (IL-2, IL-4, IL-5, IFN-γ and TNF-α) upon restimulation with inactivated SARS-CoV virion in vitro. Thus, a whole killed virion could serve as a candidate antigen for a SARS vaccine to elicit both humoral and cellular immunity.
Url:
- https://api.istex.fr/ark:/67375/HXZ-PDNM495K-Q/fulltext.pdf
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108621
DOI: 10.1093/intimm/dxh143
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000085
- to stream Istex, to step Curation: 000085
- to stream Istex, to step Checkpoint: 002081
- to stream Pmc, to step Corpus: 000B67
- to stream Pmc, to step Curation: 000B67
- to stream Pmc, to step Checkpoint: 001740
- to stream PubMed, to step Corpus: 002C13
- to stream PubMed, to step Curation: 002C13
- to stream PubMed, to step Checkpoint: 002E52
- to stream Ncbi, to step Merge: 000A09
- to stream Ncbi, to step Curation: 000A09
- to stream Ncbi, to step Checkpoint: 000A09
- to stream Main, to step Merge: 005E48
- to stream Main, to step Curation: 005A01
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice</title><author><name sortKey="Takasuka, Naomi" sort="Takasuka, Naomi" uniqKey="Takasuka N" first="Naomi" last="Takasuka">Naomi Takasuka</name></author><author><name sortKey="Fujii, Hideki" sort="Fujii, Hideki" uniqKey="Fujii H" first="Hideki" last="Fujii">Hideki Fujii</name></author><author><name sortKey="Takahashi, Yoshimasa" sort="Takahashi, Yoshimasa" uniqKey="Takahashi Y" first="Yoshimasa" last="Takahashi">Yoshimasa Takahashi</name></author><author><name sortKey="Kasai, Masataka" sort="Kasai, Masataka" uniqKey="Kasai M" first="Masataka" last="Kasai">Masataka Kasai</name></author><author><name sortKey="Morikawa, Shigeru" sort="Morikawa, Shigeru" uniqKey="Morikawa S" first="Shigeru" last="Morikawa">Shigeru Morikawa</name></author><author><name sortKey="Itamura, Shigeyuki" sort="Itamura, Shigeyuki" uniqKey="Itamura S" first="Shigeyuki" last="Itamura">Shigeyuki Itamura</name></author><author><name sortKey="Ishii, Koji" sort="Ishii, Koji" uniqKey="Ishii K" first="Koji" last="Ishii">Koji Ishii</name></author><author><name sortKey="Sakaguchi, Masahiro" sort="Sakaguchi, Masahiro" uniqKey="Sakaguchi M" first="Masahiro" last="Sakaguchi">Masahiro Sakaguchi</name></author><author><name sortKey="Ohnishi, Kazuo" sort="Ohnishi, Kazuo" uniqKey="Ohnishi K" first="Kazuo" last="Ohnishi">Kazuo Ohnishi</name></author><author><name sortKey="Ohshima, Masamichi" sort="Ohshima, Masamichi" uniqKey="Ohshima M" first="Masamichi" last="Ohshima">Masamichi Ohshima</name></author><author><name sortKey="Hashimoto, Shu Ichi" sort="Hashimoto, Shu Ichi" uniqKey="Hashimoto S" first="Shu-Ichi" last="Hashimoto">Shu-Ichi Hashimoto</name></author><author><name sortKey="Odagiri, Takato" sort="Odagiri, Takato" uniqKey="Odagiri T" first="Takato" last="Odagiri">Takato Odagiri</name></author><author><name sortKey="Tashiro, Masato" sort="Tashiro, Masato" uniqKey="Tashiro M" first="Masato" last="Tashiro">Masato Tashiro</name></author><author><name sortKey="Yoshikura, Hiroshi" sort="Yoshikura, Hiroshi" uniqKey="Yoshikura H" first="Hiroshi" last="Yoshikura">Hiroshi Yoshikura</name></author><author><name sortKey="Takemori, Toshitada" sort="Takemori, Toshitada" uniqKey="Takemori T" first="Toshitada" last="Takemori">Toshitada Takemori</name></author><author><name sortKey="Tsunetsugu Yokota, Yasuko" sort="Tsunetsugu Yokota, Yasuko" uniqKey="Tsunetsugu Yokota Y" first="Yasuko" last="Tsunetsugu-Yokota">Yasuko Tsunetsugu-Yokota</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:506B90F83AAF56295C5A0D6DAC109CB6DB03EC54</idno><date when="2004" year="2004">2004</date><idno type="doi">10.1093/intimm/dxh143</idno><idno type="url">https://api.istex.fr/ark:/67375/HXZ-PDNM495K-Q/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000085</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000085</idno><idno type="wicri:Area/Istex/Curation">000085</idno><idno type="wicri:Area/Istex/Checkpoint">002081</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002081</idno><idno type="wicri:doubleKey">0953-8178:2004:Takasuka N:a:subcutaneously:injected</idno><idno type="wicri:source">PMC</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108621</idno><idno type="RBID">PMC:7108621</idno><idno type="wicri:Area/Pmc/Corpus">000B67</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000B67</idno><idno type="wicri:Area/Pmc/Curation">000B67</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000B67</idno><idno type="wicri:Area/Pmc/Checkpoint">001740</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001740</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:15314040</idno><idno type="wicri:Area/PubMed/Corpus">002C13</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002C13</idno><idno type="wicri:Area/PubMed/Curation">002C13</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002C13</idno><idno type="wicri:Area/PubMed/Checkpoint">002E52</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002E52</idno><idno type="wicri:Area/Ncbi/Merge">000A09</idno><idno type="wicri:Area/Ncbi/Curation">000A09</idno><idno type="wicri:Area/Ncbi/Checkpoint">000A09</idno><idno type="wicri:doubleKey">0953-8178:2004:Takasuka N:a:subcutaneously:injected</idno><idno type="wicri:Area/Main/Merge">005E48</idno><idno type="wicri:Area/Main/Curation">005A01</idno><idno type="wicri:Area/Main/Exploration">005A01</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice</title><author><name sortKey="Takasuka, Naomi" sort="Takasuka, Naomi" uniqKey="Takasuka N" first="Naomi" last="Takasuka">Naomi Takasuka</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Fujii, Hideki" sort="Fujii, Hideki" uniqKey="Fujii H" first="Hideki" last="Fujii">Hideki Fujii</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Takahashi, Yoshimasa" sort="Takahashi, Yoshimasa" uniqKey="Takahashi Y" first="Yoshimasa" last="Takahashi">Yoshimasa Takahashi</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Kasai, Masataka" sort="Kasai, Masataka" uniqKey="Kasai M" first="Masataka" last="Kasai">Masataka Kasai</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Morikawa, Shigeru" sort="Morikawa, Shigeru" uniqKey="Morikawa S" first="Shigeru" last="Morikawa">Shigeru Morikawa</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Itamura, Shigeyuki" sort="Itamura, Shigeyuki" uniqKey="Itamura S" first="Shigeyuki" last="Itamura">Shigeyuki Itamura</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Ishii, Koji" sort="Ishii, Koji" uniqKey="Ishii K" first="Koji" last="Ishii">Koji Ishii</name><affiliation><wicri:noCountry code="no comma">Second and</wicri:noCountry></affiliation></author><author><name sortKey="Sakaguchi, Masahiro" sort="Sakaguchi, Masahiro" uniqKey="Sakaguchi M" first="Masahiro" last="Sakaguchi">Masahiro Sakaguchi</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Ohnishi, Kazuo" sort="Ohnishi, Kazuo" uniqKey="Ohnishi K" first="Kazuo" last="Ohnishi">Kazuo Ohnishi</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Ohshima, Masamichi" sort="Ohshima, Masamichi" uniqKey="Ohshima M" first="Masamichi" last="Ohshima">Masamichi Ohshima</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Hashimoto, Shu Ichi" sort="Hashimoto, Shu Ichi" uniqKey="Hashimoto S" first="Shu-Ichi" last="Hashimoto">Shu-Ichi Hashimoto</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Odagiri, Takato" sort="Odagiri, Takato" uniqKey="Odagiri T" first="Takato" last="Odagiri">Takato Odagiri</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Tashiro, Masato" sort="Tashiro, Masato" uniqKey="Tashiro M" first="Masato" last="Tashiro">Masato Tashiro</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Yoshikura, Hiroshi" sort="Yoshikura, Hiroshi" uniqKey="Yoshikura H" first="Hiroshi" last="Yoshikura">Hiroshi Yoshikura</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement><region type="région">Région de Kantō</region></placeName></affiliation></author><author><name sortKey="Takemori, Toshitada" sort="Takemori, Toshitada" uniqKey="Takemori T" first="Toshitada" last="Takemori">Toshitada Takemori</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Tsunetsugu Yokota, Yasuko" sort="Tsunetsugu Yokota, Yasuko" uniqKey="Tsunetsugu Yokota Y" first="Yasuko" last="Tsunetsugu-Yokota">Yasuko Tsunetsugu-Yokota</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">International Immunology</title><title level="j" type="abbrev">Int. Immunol.</title><idno type="ISSN">0953-8178</idno><idno type="eISSN">1460-2377</idno><imprint><publisher>Oxford University Press</publisher><date type="e-published">2004</date><date type="published">2004</date><biblScope unit="vol">16</biblScope><biblScope unit="issue">10</biblScope><biblScope unit="page" from="1423">1423</biblScope><biblScope unit="page" to="1430">1430</biblScope></imprint><idno type="ISSN">0953-8178</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0953-8178</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adjuvants, Immunologic (administration & dosage)</term><term>Alum Compounds (administration & dosage)</term><term>Animals</term><term>Antibody Formation</term><term>Antibody Specificity</term><term>Blotting, Western</term><term>Immunoglobulin G (blood)</term><term>Injections, Subcutaneous</term><term>Mice</term><term>SARS Virus (immunology)</term><term>Severe Acute Respiratory Syndrome (prevention & control)</term><term>Vaccines, Inactivated (administration & dosage)</term><term>Viral Proteins (immunology)</term><term>Viral Vaccines (administration & dosage)</term><term>Virion (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adjuvants immunologiques (administration et posologie)</term><term>Alun (administration et posologie)</term><term>Animaux</term><term>Immunoglobuline G (sang)</term><term>Injections sous-cutanées</term><term>Production d'anticorps</term><term>Protéines virales (immunologie)</term><term>Souris</term><term>Spécificité des anticorps</term><term>Syndrome respiratoire aigu sévère ()</term><term>Technique de Western</term><term>Vaccins antiviraux (administration et posologie)</term><term>Vaccins inactivés (administration et posologie)</term><term>Virion (immunologie)</term><term>Virus du SRAS (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Adjuvants, Immunologic</term><term>Alum Compounds</term><term>Vaccines, Inactivated</term><term>Viral Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Immunoglobulin G</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Adjuvants immunologiques</term><term>Alun</term><term>Vaccins antiviraux</term><term>Vaccins inactivés</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Protéines virales</term><term>Virion</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>SARS Virus</term><term>Viral Proteins</term><term>Virion</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Immunoglobuline G</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Antibody Formation</term><term>Antibody Specificity</term><term>Blotting, Western</term><term>Injections, Subcutaneous</term><term>Mice</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Injections sous-cutanées</term><term>Production d'anticorps</term><term>Souris</term><term>Spécificité des anticorps</term><term>Syndrome respiratoire aigu sévère</term><term>Technique de Western</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The recent emergence of severe acute respiratory syndrome (SARS) was caused by a novel coronavirus, SARS-CoV. It spread rapidly to many countries and developing a SARS vaccine is now urgently required. In order to study the immunogenicity of UV-inactivated purified SARS-CoV virion as a vaccine candidate, we subcutaneously immunized mice with UV-inactivated SARS-CoV with or without an adjuvant. We chose aluminum hydroxide gel (alum) as an adjuvant, because of its long safety history for human use. We observed that the UV-inactivated SARS-CoV virion elicited a high level of humoral immunity, resulting in the generation of long-term antibody secreting and memory B cells. With the addition of alum to the vaccine formula, serum IgG production was augmented and reached a level similar to that found in hyper-immunized mice, though it was still insufficient to elicit serum IgA antibodies. Notably, the SARS-CoV virion itself was able to induce long-term antibody production even without an adjuvant. Anti-SARS-CoV antibodies elicited in mice recognized both the spike and nucleocapsid proteins of the virus and were able to neutralize the virus. Furthermore, the UV-inactivated virion induced regional lymph node T-cell proliferation and significant levels of cytokine production (IL-2, IL-4, IL-5, IFN-γ and TNF-α) upon restimulation with inactivated SARS-CoV virion in vitro. Thus, a whole killed virion could serve as a candidate antigen for a SARS vaccine to elicit both humoral and cellular immunity.</div></front></TEI><affiliations><list><country><li>Japon</li></country><region><li>Région de Kantō</li></region><settlement><li>Tokyo</li></settlement></list><tree><noCountry><name sortKey="Fujii, Hideki" sort="Fujii, Hideki" uniqKey="Fujii H" first="Hideki" last="Fujii">Hideki Fujii</name><name sortKey="Hashimoto, Shu Ichi" sort="Hashimoto, Shu Ichi" uniqKey="Hashimoto S" first="Shu-Ichi" last="Hashimoto">Shu-Ichi Hashimoto</name><name sortKey="Ishii, Koji" sort="Ishii, Koji" uniqKey="Ishii K" first="Koji" last="Ishii">Koji Ishii</name><name sortKey="Itamura, Shigeyuki" sort="Itamura, Shigeyuki" uniqKey="Itamura S" first="Shigeyuki" last="Itamura">Shigeyuki Itamura</name><name sortKey="Kasai, Masataka" sort="Kasai, Masataka" uniqKey="Kasai M" first="Masataka" last="Kasai">Masataka Kasai</name><name sortKey="Morikawa, Shigeru" sort="Morikawa, Shigeru" uniqKey="Morikawa S" first="Shigeru" last="Morikawa">Shigeru Morikawa</name><name sortKey="Odagiri, Takato" sort="Odagiri, Takato" uniqKey="Odagiri T" first="Takato" last="Odagiri">Takato Odagiri</name><name sortKey="Ohnishi, Kazuo" sort="Ohnishi, Kazuo" uniqKey="Ohnishi K" first="Kazuo" last="Ohnishi">Kazuo Ohnishi</name><name sortKey="Ohshima, Masamichi" sort="Ohshima, Masamichi" uniqKey="Ohshima M" first="Masamichi" last="Ohshima">Masamichi Ohshima</name><name sortKey="Sakaguchi, Masahiro" sort="Sakaguchi, Masahiro" uniqKey="Sakaguchi M" first="Masahiro" last="Sakaguchi">Masahiro Sakaguchi</name><name sortKey="Takahashi, Yoshimasa" sort="Takahashi, Yoshimasa" uniqKey="Takahashi Y" first="Yoshimasa" last="Takahashi">Yoshimasa Takahashi</name><name sortKey="Takasuka, Naomi" sort="Takasuka, Naomi" uniqKey="Takasuka N" first="Naomi" last="Takasuka">Naomi Takasuka</name><name sortKey="Takemori, Toshitada" sort="Takemori, Toshitada" uniqKey="Takemori T" first="Toshitada" last="Takemori">Toshitada Takemori</name><name sortKey="Tashiro, Masato" sort="Tashiro, Masato" uniqKey="Tashiro M" first="Masato" last="Tashiro">Masato Tashiro</name><name sortKey="Tsunetsugu Yokota, Yasuko" sort="Tsunetsugu Yokota, Yasuko" uniqKey="Tsunetsugu Yokota Y" first="Yasuko" last="Tsunetsugu-Yokota">Yasuko Tsunetsugu-Yokota</name></noCountry><country name="Japon"><region name="Région de Kantō"><name sortKey="Yoshikura, Hiroshi" sort="Yoshikura, Hiroshi" uniqKey="Yoshikura H" first="Hiroshi" last="Yoshikura">Hiroshi Yoshikura</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005A01 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005A01 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:506B90F83AAF56295C5A0D6DAC109CB6DB03EC54
|texte= A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice
}}
| This area was generated with Dilib version V0.6.33. |  |